Problem: Understanding Polygenic Risk Scores (PRS) clinical utility and limitations can be a significant challenge. Solution: An evaluation of clinical evidence and laboratory validation data will assist you in identifying the most accurate and clinically...
Center For Genomic Interpretation (CGI) is very excited to share the interview edition of our monthly newsletter. Justin Zook, Ph.D. is the Co-Leader of Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST). In the...
Problem: What exactly is a physician’s role and responsibility when testing patients for genetic abnormalities? The American College of Physicians (ACOP) recently released a position paper discussing just this issue. Precision medicine raises many issues...
The Medical Device Innovation Consortium (MDIC) is launching a new initiative testing somatic (tissue) reference samples to improve validation, as well as the regulatory review process for cancer diagnostic testing based on next generation sequencing (NGS). This will...
Problem: How can YOU maximize value in precision medicine? Is precision medicine truly precise? The American Journal of Clinical Pathology recently published an article stating that only 37% of NGS oncology clinical labs reported ALL important mutations in their...
Last year, Grail reported that 44.6% of patients with positive test results on Galleri actually had cancer. Galleri is a multi-cancer early detection test. However, in the latest analysis, the figure, known as the positive predictive value, has fallen to 38.0%. This...
In this episode of The Rising Tide Podcast, Dr. Justin Zook, Co-Leader, Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST) sits down with the Center For Genomic Interpretation to discuss the Genome In a Bottle (GIAB)...
Salt Lake, UT / PRWeb / Sept 20, 2022 – The Center for Genomic Interpretation (CGI) continues hosting its cutting-edge Rising Tide Podcast series, which features nationally-recognized experts in precision medicine. In Episode 6, the CGI Podcast features an interview...
Problem: There are systematic problems with accuracy in CLINICAL GENETICS & GENOMICS. Also, accustomed to self-policing, the genetics and genomics lab community express concerns about quality threshold requirements from insurance payors. This thinking and...
“A Texas doctor pleaded guilty today for his role in a $54 million scheme to defraud Medicare by prescribing durable medical equipment and cancer genetic testing without ever seeing, speaking to, or otherwise treating patients.” #Cancer#genetictesting was ordered for...